Abstract
Diagnostic imaging based on the Nuclear Magnetic Resonance phenomenon has increasingly spread in the recent few decades, mainly owing to its exquisite capability in depicting a contrast between soft tissues, to its generally non-invasive nature, and to the priceless advantage of using non-ionizing radiation. Magnetic Resonance (MR)-based acquisition techniques allow gathering information on the structure (through Magnetic Resonance Imaging— MRI), the metabolic composition (through Magnetic Resonance Spectroscopy—MRS), and the functioning (through functional MRI —fMRI) of the human body. MR investigations are the methods of choice for studying the brain in vivo, including anatomy, structural wiring and functional connectivity, in healthy and pathological conditions. Alongside the efforts of the clinical research community in extending the acquisition protocols to allow the exploration of a large variety of pathologies affecting diverse body regions, some relevant technological improvements are on the way to maximize the impact of MR in medical diagnostic. The development of MR scanners operating at ultra-high magnetic field (UHF) strength (⩾ 7 tesla), is pushing forward the spatial resolution of MRI and the spectral resolution of MRS, and it is increasing the specificity of fMRI to grey matter signal. UHF MR systems are currently in use for research purposes only; nevertheless, UHF technological advances are positively affecting MR investigations at clinical field strengths. To overcome the current major limitation of MRI, which is mostly based on contrast between tissues rather than on absolute measurements of physical quantities, a new acquisition modality is under development, which is referred as Magnetic Resonance Fingerprinting technique. Finally, as neuroimaging data acquired worldwide are reaching the typical size of Big Data, dedicated technical solutions are required to mine large amount of information and to identify specific biomarkers of pathological conditions.